A reduction of Nav1.5 expression in mice with a heterozygous knockout (SCN5A+/−) reduced 50% of INa conduction and resolved ventricular tachycardia and conduction defects [21], which recapitulated clinical observations in humans. Here, SCN5A is linked to ventricular tachycardia.